Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
EV to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
4049.26
↑ 439% above average
Average (9y)
751.11
Historical baseline
Range
High:4049.26
Low:-0.34
CAGR
+71.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 4049.26 | +42.4% |
| 2023 | 2843.93 | +540.4% |
| 2022 | 444.10 | +578.8% |
| 2021 | 65.42 | +425.5% |
| 2020 | 12.45 | +3801.1% |
| 2019 | -0.34 | -104.2% |
| 2018 | 8.03 | -80.3% |
| 2017 | 40.77 | +162.0% |
| 2016 | 15.56 | -51.3% |
| 2015 | 31.94 | - |